相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。LncRNA T376626 is a promising serum biomarker and promotes proliferation, migration, and invasion via binding to LAMC2 in triple-negative breast cancer
Yongyin He et al.
GENE (2023)
IL-6 Cytokine Family: A Putative Target for Breast Cancer Prevention and Treatment
Carla M. Felcher et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2022)
Pan-cancer analysis on the role of PIK3R1 and PIK3R2 in human tumors
Yane Liu et al.
SCIENTIFIC REPORTS (2022)
Exploring the Potential of Exosome-Related LncRNA Pairs as Predictors for Immune Microenvironment, Survival Outcome, and Microbiotain Landscape in Esophageal Squamous Cell Carcinoma
Fangchao Zhao et al.
FRONTIERS IN IMMUNOLOGY (2022)
The Role of MicroRNA in the Regulation of Tumor Epithelial-Mesenchymal Transition
Jing Feng et al.
CELLS (2022)
Advances in MUC1-Mediated Breast Cancer Immunotherapy
Zhifeng Li et al.
BIOMOLECULES (2022)
Exploring the NK cell platform for cancer immunotherapy
Jacob A. Myers et al.
NATURE REVIEWS CLINICAL ONCOLOGY (2021)
LAMC2 promotes cancer progression and gemcitabine resistance through modulation of EMT and ATP-binding cassette transporters in pancreatic ductal adenocarcinoma
Yasuyuki Okada et al.
CARCINOGENESIS (2021)
MMP11 promotes the proliferation and progression of breast cancer through stabilizing Smad2 protein
Ying Zhuang et al.
ONCOLOGY REPORTS (2021)
EMT-associated microRNAs and their roles in cancer stemness and drug resistance
Guangtao Pan et al.
CANCER COMMUNICATIONS (2021)
Tumor Immune Microenvironment during Epithelial-Mesenchymal Transition
Mana Taki et al.
CLINICAL CANCER RESEARCH (2021)
Cancer statistics for the year 2020: An overview
Jacques Ferlay et al.
INTERNATIONAL JOURNAL OF CANCER (2021)
Graphene-based nanomaterials for breast cancer treatment: promising therapeutic strategies
Guangman Cui et al.
JOURNAL OF NANOBIOTECHNOLOGY (2021)
MiRNAs and Cancer: Key Link in Diagnosis and Therapy
Yu Shi et al.
GENES (2021)
Loss of neuropilin 1 inhibits liver cancer stem cells population and blocks metastasis in hepatocellular carcinoma via epithelial-mesenchymal transition
Xun Li et al.
NEOPLASMA (2021)
Neuropilin-1 predicts poor prognosis and promotes tumor metastasis through epithelial-mesenchymal transition in gastric cancer
Qianna Jin et al.
JOURNAL OF CANCER (2021)
Intrahepatic Cholangiocarcinoma Cells Promote Epithelial-mesenchymal Transition of Hepatocellular Carcinoma Cells by Secreting LAMC2
Wenda Cen et al.
JOURNAL OF CANCER (2021)
Identification of prognostic significance of BIRC5 in breast cancer using integrative bioinformatics analysis
Jian-bo Gai et al.
BIOSCIENCE REPORTS (2020)
Cancer statistics, 2020
Rebecca L. Siegel et al.
CA-A CANCER JOURNAL FOR CLINICIANS (2020)
Diagnostic value of Doppler ultrasound parameters combined with MMP-11 in early breast cancer and benign breast diseases
Hui Ren et al.
ONCOLOGY LETTERS (2020)
Neuropilin-1: a checkpoint target with unique implications for cancer immunology and immunotherapy
Christopher A. Chuckran et al.
JOURNAL FOR IMMUNOTHERAPY OF CANCER (2020)
Survivin in breast cancer-derived exosomes activates fibroblasts by up-regulating SOD1, whose feedback promotes cancer proliferation and metastasis
Kangdi Li et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2020)
EMT, MET, Plasticity, and Tumor Metastasis
Basil Bakir et al.
TRENDS IN CELL BIOLOGY (2020)
Role of Tropomyosin-related kinase B receptor and brain-derived neurotrophic factor in cancer
Vilson Serafim Junior et al.
CYTOKINE (2020)
Wnt signaling in breast cancer: biological mechanisms, challenges and opportunities
Xiufang Xu et al.
MOLECULAR CANCER (2020)
EMT in breast cancer metastasis: an interplay of microRNAs, signaling pathways and circulating tumor cells
Aviral Kumar et al.
FRONTIERS IN BIOSCIENCE-LANDMARK (2020)
EGFR-targeted CAR-T cells are potent and specific in suppressing triple-negative breast cancer both in vitro and in vivo
Lin Xia et al.
CLINICAL & TRANSLATIONAL IMMUNOLOGY (2020)
Somatic loss of PIK3R1 may sensitize breast cancer to inhibitors of the MAPK pathway
Sanja B. Turturro et al.
BREAST CANCER RESEARCH AND TREATMENT (2019)
miR-221/222 promote tumor growth and suppress apoptosis by targeting lncRNA GAS5 in breast cancer
Yuanyuan Zong et al.
BIOSCIENCE REPORTS (2019)
An overview of microRNAs: Biology, functions, therapeutics, and analysis methods
Kioomars Saliminejad et al.
JOURNAL OF CELLULAR PHYSIOLOGY (2019)
STRING v11: protein-protein association networks with increased coverage, supporting functional discovery in genome-wide experimental datasets
Damian Szklarczyk et al.
NUCLEIC ACIDS RESEARCH (2019)
dbEMT 2.0: An updated database for epithelial-mesenchymal transition genes with experimentally verified information and precalculated regulation information for cancer metastasis
Min Zhao et al.
JOURNAL OF GENETICS AND GENOMICS (2019)
Evaluation of a novel monoclonal antibody against tumor-associated MUC1 for diagnosis and prognosis of breast cancer
Natascha Stergiou et al.
INTERNATIONAL JOURNAL OF MEDICAL SCIENCES (2019)
Machine Learning Identifies Stemness Features Associated with Oncogenic Dedifferentiation
Tathiane M. Malta et al.
CELL (2018)
Expression Analysis of MicroRNA-222 in Breast Cancer
Sima Amini et al.
CLINICAL LABORATORY (2018)
Epithelial-mesenchymal transition induced PAI-1 is associated with prognosis of triple-negative breast cancer patients
Jing Xu et al.
GENE (2018)
Interleukin-6/STAT3 signalling regulates adipocyte induced epithelial-mesenchymal transition in breast cancer cells
Jones Gyamfi et al.
SCIENTIFIC REPORTS (2018)
miRWalk: An online resource for prediction of microRNA binding sites
Carsten Sticht et al.
PLOS ONE (2018)
The significant role of interleukin-6 and its signaling pathway in the immunopathogenesis and treatment of breast cancer
Ali Masjedi et al.
BIOMEDICINE & PHARMACOTHERAPY (2018)
Dendritic Cells and CD8 T Cell Immunity in Tumor Microenvironment
Chunmei Fu et al.
FRONTIERS IN IMMUNOLOGY (2018)
Recent insights into targeting the IL-6 cytokine family in inflammatory diseases and cancer
Simon A. Jones et al.
NATURE REVIEWS IMMUNOLOGY (2018)
MiR-221/222 promote epithelial-mesenchymal transition by targeting Notch3 in breast cancer cell lines
Yuan-Ke Liang et al.
NPJ BREAST CANCER (2018)
MUC1 induces tamoxifen resistance in estrogen receptor-positive breast cancer
Parnaz Merikhian et al.
EXPERT REVIEW OF ANTICANCER THERAPY (2017)
EMT, CSCs, and drug resistance: the mechanistic link and clinical implications
Tsukasa Shibue et al.
NATURE REVIEWS CLINICAL ONCOLOGY (2017)
Analysis of 100,000 human cancer genomes reveals the landscape of tumor mutational burden
Zachary R. Chalmers et al.
GENOME MEDICINE (2017)
Landscape of Microsatellite Instability Across 39 Cancer Types
Russell Bonneville et al.
JCO PRECISION ONCOLOGY (2017)
PIK3R1 targeting by miR-21 suppresses tumor cell migration and invasion by reducing PI3K/AKT signaling and reversing EMT, and predicts clinical outcome of breast cancer
Li-Xu Yan et al.
INTERNATIONAL JOURNAL OF ONCOLOGY (2016)
The role of HER2, EGFR, and other receptor tyrosine kinases in breast cancer
Jennifer L. Hsu et al.
CANCER AND METASTASIS REVIEWS (2016)
The downregulation of miR-125a-5p functions as a tumor suppressor by directly targeting MMP-11 in osteosarcoma
Niyazi Waresijiang et al.
MOLECULAR MEDICINE REPORTS (2016)
Hypoxia-inducible factor 1 and breast cancer metastasis
Zhao-ji Liu et al.
JOURNAL OF ZHEJIANG UNIVERSITY-SCIENCE B (2015)
Review The Cancer Genome Atlas (TCGA): an immeasurable source of knowledge
Katarzyna Tomczak et al.
Wspolczesna Onkologia-Contemporary Oncology (2015)
A new role for the PI3K/Akt signaling pathway in the epithelial-mesenchymal transition
Wenting Xu et al.
CELL ADHESION & MIGRATION (2015)
Induction of metastatic potential by TrkB via activation of IL6/JAK2/STAT3 and PI3K/AKT signaling in breast cancer
Min Soo Kim et al.
ONCOTARGET (2015)
Neuropilin 1: function and therapeutic potential in cancer
Belal Chaudhary et al.
CANCER IMMUNOLOGY IMMUNOTHERAPY (2014)
IGF-1-induced epithelial-mesenchymal transition in MCF-7 cells is mediated by MUC1
Gaoyong Liao et al.
CELLULAR SIGNALLING (2014)
miR-221/222 Promotes S-Phase Entry and Cellular Migration in Control of Basal-Like Breast Cancer
Yuan Li et al.
MOLECULES (2014)
uPA and PAI-1 as biomarkers in breast cancer: validated for clinical use in level-of-evidence-1 studies
Michael J. Duffy et al.
BREAST CANCER RESEARCH (2014)
GSVA: gene set variation analysis for microarray and RNA-Seq data
Sonja Haenzelmann et al.
BMC BIOINFORMATICS (2013)
PIK3R1 underexpression is an independent prognostic marker in breast cancer
Magdalena Cizkova et al.
BMC CANCER (2013)
Genomics of Drug Sensitivity in Cancer (GDSC): a resource for therapeutic biomarker discovery in cancer cells
Wanjuan Yang et al.
NUCLEIC ACIDS RESEARCH (2013)
miR-221/222 Targets Adiponectin Receptor 1 to Promote the Epithelial-to-Mesenchymal Transition in Breast Cancer
Michael S. Hwang et al.
PLOS ONE (2013)
Multiple-to-Multiple Relationships between MicroRNAs and Target Genes in Gastric Cancer
Yutaka Hashimoto et al.
PLOS ONE (2013)
Role of epidermal growth factor receptor in breast cancer
Hiroko Masuda et al.
BREAST CANCER RESEARCH AND TREATMENT (2012)
miR221/222 in Cancer: Their Role in Tumor Progression and Response to Therapy
M. Garofalo et al.
CURRENT MOLECULAR MEDICINE (2012)
MicroRNA-203 suppresses cell proliferation and migration by targeting BIRC5 and LASP1 in human triple-negative breast cancer cells
Chen Wang et al.
JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH (2012)
Ectopic Expression of MiR-125a Inhibits the Proliferation and Metastasis of Hepatocellular Carcinoma by Targeting MMP11 and VEGF
Qian Bi et al.
PLOS ONE (2012)
EGFR signaling pathway and related-miRNAs in age-related diseases: the example of miR-221 and miR-222
Ana L. Teixeira et al.
Frontiers in Genetics (2012)
miR-221/222 Targeting of Trichorhinophalangeal 1 (TRPS1) Promotes Epithelial-to-Mesenchymal Transition in Breast Cancer
Susanna Stinson et al.
SCIENCE SIGNALING (2011)
MicroRNA Cluster 221-222 and Estrogen Receptor α Interactions in Breast Cancer
Gianpiero Di Leva et al.
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE (2010)
The epithelial-mesenchymal transition generates cells with properties of stem cells
Sendurai A. Mani et al.
CELL (2008)
Stromelysin-3 over-expression enhances tumourigenesis in MCF-7 and MDA-MB-231 breast cancer cell lines: involvement of the IGF-1 signalling pathway
Grit Kasper et al.
BMC CANCER (2007)
分享论文
